Treatment of canine haemangiosarcoma with suberoylanilide hydroxamic acid, a histone deacetylase inhibitor

A case report is presented by describing the treatment of a 12‐year‐old dog – diagnosed with haemangiosarcoma (HSA) – with suberoylanilide hydroxamic acid (SAHA), a histone deacetylase (HDAC) inhibitor. The drug was administered orally, on a daily basis, approximately 2 weeks post‐splenectomy at a dose of 3 mg kg^?1. HSA is a lethal malignancy of the endothelium, which is usually disseminated by the time it is diagnosed. Median survival time, usually, is no longer than 80 days. Following treatment with SAHA, no sign of malignant growth could be discerned by means of diagnostic abdominal ultrasound, chest X‐ray or with the help of clinical symptoms, over a period of >1000 days. The precise mechanism by which HDAC inhibitors exert their anti‐cancer effects is uncertain, but evidence suggests that exposure to SAHA generates hyperacetylated chromosomal histones, which, in turn, facilitates the expression of tumour suppressor genes turned off by epigenetic mechanisms during neoplastic transformation of the endothelium.     

Use of intralesional cisplatin to successfully treat distal limb haemangiosarcoma in a foal

A 4-month old, 200 kg, grey warmblood colt presented for a firm, non painful mass on the distal medial aspect of the left third metatarsus. Excisional biopsy revealed a diagnosis of haemangiosarcoma. Equine haemangiosarcoma is uncommon and only limited reports of successful treatment are available. The prognosis for survival is therefore considered to be poor. After two separate incidences of recurrence with incomplete excision of the tumour, intralesional treatment with cisplatin without excision or debulking was performed on three separate occasions. Intralesional cisplatin injection was performed at monthly intervals for three treatments. Four years post treatment with cisplatin, the horse remained in remission. This case report describes the diagnostic and treatment challenges for successful treatment of a primary haemangiosarcoma on the distal limb of a warmblood foal using intralesional cisplatin chemotherapy.     

Haemangiosarcoma in the horse

Neoplasms arising from vascular endothelial cells include benign haemangioma and malignant haemangiosarcoma, both of which are rare in the horse. Haemangiosarcoma can arise as a solitary mass, typically involving the eye or skin, or as disseminated tumours throughout multiple organs. There is no sex, breed or age predilection but most cases are found in middle aged horses. Clinical presentations of haemangiosarcoma in the horse include the presence of a visible mass or reflect dysfunction of the organ involved, thus making it difficult to differentiate from other neoplasms. Ante mortem diagnosis through clinicopathological findings, cytological findings of body cavity effusions or fine needle aspirates are often unrewarding. Biopsy or mass submission for histopathological examination may aid in diagnosis of haemangiosarcoma. A majority of cases are diagnosed post mortem; however, if the mass is poorly differentiated additional diagnostics such as immunohistochemical staining may be needed. Unfortunately, treatment of haemangiosarcoma is often unrewarding and limited based on the location of the mass and the aggressive nature of this neoplasm.     

The Pathology of Vinyl Chloride Exposed Mice

Outbred albino laboratory mice were exposed to 50 p.p.m. and 500 p.p.m. vinyl chloride by inhalation 6 hrs./day, 5 days/week during 52 and 26 weeks, respectively. Pathologic examination showed the presence of histologically benign alveologenic lung adenomas, haem-angiosarcomas in fat tissue as well as a few benign and malignant tumours at various sites. Only one liver haemangiosarcoma was noted. All animals exposed to 500 p.p.m. developed tumours; 71 % of the animals given 50 p.p.m. were tumour bearing. The frequency of all tumours, number of tumour foci and size of foci in both groups suggest a dose-dependent carcinogenic effect of vinyl chloride. Haemocoelia due to blood vessel rupture was a common cause of death. Telangiectasis of the liver was also observed in a few animals. The role of fat tissue as well as blood vessel involvement in the pathology of vinyl chloride is discussed.     

Anthelmintic use in goats and the effect of route of administration

The control of gastrointestinal parasites in goats by the use of anthelmintics has been and continues to be problematic. Products used successfully in sheep sometimes appear to be less effective than expected when used in goats. Parasites resistant to ivermectin have been reported in goats in New Zealand but not in sheep. I write to report a case that raises issues pertaining to the relative effectiveness of different routes of anthelmintic administration in goats.     

Primary haemangiosarcoma in the proximal humerus of a Clydesdale gelding

An 11‐year‐old Clydesdale gelding was presented for investigation of left forelimb lameness of 2 weeks' duration. The use of scintigraphic imaging helped to localise the source of lameness to the left proximal humerus. In this report, the clinical and diagnostic imaging features of a primary osseous haemangiosarcoma in a horse are described, along with the challenges of establishing a definitive diagnosis ante mortem. In addition, neoplasia of the appendicular skeleton should be considered a differential cause of lameness in the horse.     

Penile haemangiosarcoma in a breeding stallion

A 9‐year‐old Arab stallion was presented for haematuria and a haemorrhagic mass on the urethral process of the penis. Clinical examination and surgical excision suggested a tumour of the penis, histologically confirmed as a haemangiosarcoma. The stallion was successfully treated with surgical excision; however, successful breeding has not been achieved thus far (28 months). To the authors' knowledge, haemangiosarcoma of the equine penis has not previously been described.     

Interstitial brachytherapy in the management of haemangiosarcoma of the rostrum of the horse: Case report and review of the literature

Sarcomas arising in the equine species are rare tumours, and treatment is generally surgical. Radiotherapy has been used in the management of malignancies of large animals; however, conventional external radiotherapy delivery is difficult. Interstitial brachytherapy has been used in the management of human sarcomas with reasonable success, although equine experience is minimal. We report a case of equine haemangiosarcoma treated with brachytherapy demonstrating the feasibility of the procedure and the highly malignant natural history of haemangiosarcoma. An 8‐year‐old American Saddlebred gelding presented for evaluation of a soft tissue mass on the forehead which had been present for at least 6 months. Initial surgical attempts at management were unsuccessful; therefore a radiation oncologist specialising in brachytherapy was consulted. The radiation oncologist and veterinary surgeon performed an interstitial implant of the tumour mass on the rostrum of the horse under general anaesthesia. The procedure was well tolerated by the horse. The tumour demonstrated immediate response and was noted to have completely regressed within 6 weeks of the implant removal. Unfortunately, the horse developed widespread metastatic disease and required euthanasia. At the time of necropsy, no visible tumour was identified at the implant site. Interstitial brachytherapy is feasible in soft tissue sarcomas of the horse; however, supportive demands are great with this procedure and we recommend it only be done at large speciality centres.     

Efficacy of doxorubicin‐based chemotherapy for non‐resectable canine subcutaneous haemangiosarcoma

Eighteen dogs with measurable subcutaneous haemangiosarcoma (SQHSA) were treated with doxorubicin‐based chemotherapy. Response assessment was evaluated and compared using World Health Organization (WHO), Response Evaluation Criteria in Solid Tumours (RECIST) and tumour volume criteria. The overall response rate for all dogs was 38.8% using WHO criteria, 38.8% using RECIST criteria and 44% using tumour volume criteria. One dog had a complete response. The median response duration for all dogs was 53 days (range 13–190 days). Four dogs had complete surgical excision after neoadjuvant chemotherapy. The median progression‐free interval for dogs with complete surgical excision after neoadjuvant chemotherapy was significantly longer than those not having surgical excision (207 days versus 83 days, respectively) (P = 0.003). No significant difference in metastasis‐free interval or survival time was found between the groups. Doxorubicin‐based chemotherapy appears to be effective for non‐resectable canine SQHSA, although the response duration is relatively short.     

Disseminated haemangiosarcoma in an eastern barred bandicoot (Perameles gunnii)

A captive adult male Eastern barred bandicoot (Perameles gunnii) presented with three palpable subcutaneous masses in November 1998. A diagnosis of haemangiosarcoma was made based on histological examination of one excised mass. Euthanasia of the animal was performed 11 days postsurgery and a proliferative lesion in the paralumbar musculature and similar, smaller proliferative lesions surrounding the right popliteal lymph node and in the ventricular wall of the heart were found. Metastatic lesions were found in the liver and lung. The histological features of the neoplastic tissues supported the diagnosis of a poorly differentiated, disseminated haemangiosarcoma. This is the first reported case of haemangiosarcoma in the Eastern barred bandicoot.